主 办:北 京 中 医 药 大 学
ISSN 1006-2157 CN 11-3574/R

JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE ›› 2020, Vol. 43 ›› Issue (5): 363-367.doi: 10.3969/j.issn.1006-2157.2020.05.002

• COVID 2019 Forum • Previous Articles     Next Articles

Traditional Chinese medical strategy in the management of the corona virus disease 2019 during recovery period*

Yang Xianzhao1, Du Hongbo1, He Weili1, Zhang Jingfeng2, Liu Ning1, Cui Jie2, Chen Zhengguang1, Du Yong2, Ye Yong’an1#   

  1. 1. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China;
    2. Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China
  • Received:2020-03-02 Published:2020-06-08
  • Contact: Prof. Ye Yong’an,MD, Chief Physician, Doctoral Supervisor, Dongzhimen Hospital, Beijing University of Chinese Medicine. Dongcheng District, Hai Yun Cang on the 5th Zip, Beijing 100700. E-mail: yeyongan@vip.163.com
  • Supported by:
    The Young Scientist Development Program of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (No. DZMYS-201809)

Abstract: It has been more than two months since the outbreak of Corona Virus Disease 2019 (COVID-19), and the overall epidemic situation is now under effective control with the number of cured discharged cases surpassing existing confirmed ones. Although the general condition of discharged patients has been improved to a certain extent, quite a number of them still have clinical symptoms and organ injury. Therefore, follow-up rehabilitation treatment for these patients is of great importance. Our team went to Wuhan, the center of epidemic regions, to assist clinical treatment using traditional Chinese medicine. From our experience, we found the course of the disease is relatively long, and that the problem of pulmonary fibrosis is more prominent during the recovery period. Most COVID-19 patients at the recovery stage tend to present with a complicated state of multiple patterns, characterized by dominant qi deficiency, increasing severity of blood stasis together with remaining excess of pathogens. Based on field observations, we hold that the qi deficiency and blood stasis is the core pathogenesis. Therefore, management of COVID-19 patients during the recovery period should target at pulmonary fibrosis as the key pathology by using qi-tonifying blood-activating treatment as the basic principle, combined with methods of clearing away the remaining pathogenic factors. Flexible medicinal modification could help patients recover better.

Key words: COVID-19, recovery period, traditional Chinese medicine, prevention and preatment strategy

CLC Number: 

  • R254.3